Need Support?
Endocrine billing carries a coding structure few specialties match: dynamic stimulation/suppression testing requiring timed blood draws, a drug administration component, and dedicated CPT codes billed per analyte per timepoint. Add reflex thyroid antibody rules, diabetes monitoring frequencies, and time-sensitive hormone draws, and generalists routinely misbill it. The loss compounds until an audit reveals it.
Evocative/Suppression Panel Unit Miscounting
Missing Drug Administration & Injection Billing on Stimulation Tests
Thyroid Reflex Testing Capture Gaps
Hormone Level Timing & Medical Necessity Denials
Thyroid-stimulating hormone (84443), free T4 (84439), free T3 (84481), thyroid peroxidase and thyroglobulin antibodies (86376, 86800), and thyroglobulin level (84432) used to diagnose and monitor hypothyroidism, hyperthyroidism, and autoimmune thyroid disease.
Reflex protocols that trigger free T4 or antibody testing off an abnormal TSH must be built into the ordering workflow --- missing that reflex step is one of the most common sources of uncollected revenue in routine thyroid management.
Dedicated multi-unit panel codes covering ACTH stimulation testing for adrenal insufficiency (80400), dexamethasone suppression panels (80420), growth hormone stimulation and suppression panels (80428, 80430), gonadotropin panels (80426), and the rapid combined anterior pituitary evaluation panel (80418).
Each of these codes represents a specific number of analyte measurements across defined timepoints, and the units billed must match the actual number of timed draws performed --- undercounting units on a multi-hour stimulation test is one of the most consistently underbilled services in endocrinology.
Administration of the stimulating or suppressing agent used in evocative testing, such as cosyntropin for an ACTH stimulation test or dexamethasone for a suppression test, billed separately from the laboratory panel code itself using the appropriate injection administration and drug codes.
The administration code and the drug itself are billed as distinct line items alongside the evocative testing panel code --- treating the injection as bundled into the lab panel is a routine source of underbilling on every dynamic testing encounter.
Cortisol level testing (82533), adrenocorticotropic hormone (82024), aldosterone (82088), and renin activity (84244), used individually or as part of a broader diagnostic workup for adrenal insufficiency, Cushing syndrome, and primary aldosteronism.
Cortisol and ACTH follow a strong diurnal rhythm, and collection time relative to that rhythm should be documented --- a level drawn at the wrong time of day is both clinically less interpretable and more likely to be questioned on medical necessity review.
Follicle-stimulating hormone (83001), luteinizing hormone (83002), estradiol (82670), free and total testosterone (84402, 84403), and prolactin (84146), used to evaluate infertility, hypogonadism, and pituitary dysfunction in both male and female patients.
These hormone levels are cycle-day or time-of-day dependent, and documenting the specimen collection context relative to that dependency is increasingly a medical necessity requirement, not just a clinical best practice.
Hemoglobin A1c (83036), fasting and random glucose (82947), glucose tolerance testing (82951), C-peptide (84681), and insulin level (83525), used to diagnose and monitor diabetes and evaluate insulin-secreting tumors.
Hemoglobin A1c testing is subject to payer-specific frequency limits, typically no more than four times per year for stable patients --- billing beyond that frequency without a documented treatment change is a routine, avoidable denial.
Parathyroid hormone (83970), vitamin D 25-hydroxy (82306), total and ionized calcium (82310, 82330), used to evaluate hyperparathyroidism, hypoparathyroidism, osteoporosis risk, and vitamin D deficiency.
Vitamin D testing carries some of the tightest frequency and medical necessity scrutiny in the endocrine test menu --- claims without a documented risk factor or symptomatic indication are among the most commonly denied in this category.
Calcitonin (82308) for medullary thyroid carcinoma surveillance, plasma or urine metanephrines (83835) for pheochromocytoma and paraganglioma workup, and other specialized endocrine tumor markers reported under unlisted chemistry codes when no specific CPT code exists.
Unlisted code claims require a detailed cover letter describing the exact test performed and its clinical necessity --- submitting an unlisted code without that documentation is one of the most reliable ways to guarantee a denial.
TransLabs’ specialized RCM services are built exclusively for labs, addressing the unique challenges that generalist billers miss. We provide end-to-end revenue cycle solutions designed specifically to turn laboratory complexity into profitability.
Complete payer enrollment, CLIA certification management, and network participation setup across all insurance carriers. TransLabs manages every credentialing detail so that your laboratory gets paid in-network from day one without any administrative delays.
Real-time insurance verification, benefits investigation, and prior auth completed before specimen processing begins. Confirming coverage upfront eliminates preventable denials and protects your lab from unexpected reimbursement failures.
Patient registration, appointment coordination, insurance verification, and customer service excellence managed by experienced laboratory billing professionals. A well-run front office reduces downstream billing errors and creates a better experience.
TransLabs provides expert RCM services to clinical laboratories in all 50 states, delivering the same exceptional results whether you’re a community hospital lab or a large reference facility. We bring specialized lab billing expertise to facilities nationwide, combining remote efficiency with hands-on partnership.
Each evocative or suppression testing panel code represents a specific, defined number of analyte measurements across timed intervals, and Medicare expects the units billed to exactly match the documented draws. TransLabs validates unit counts against the testing protocol documented in the chart before submission.
Each Medicare Administrative Contractor maintains its own LCD specifying which ICD-10 diagnoses support coverage for thyroid, vitamin D, and specialized hormone testing. TransLabs maintains live LCD databases and validates diagnosis-to-test linkage on every Medicare claim before submission.
Medicare and most commercial payers limit hemoglobin A1c testing frequency for stable diabetic patients, typically to four times per year, unless a documented treatment change justifies more frequent testing. TransLabs monitors each patient's testing history against these limits before submission.
Vitamin D testing faces some of the tightest medical necessity scrutiny in the endocrine test menu, with many payers requiring a documented risk factor, malabsorption condition, or specific symptomatic indication. TransLabs validates this documentation before claims are submitted.
Reflex testing, such as free T4 or thyroid antibody panels triggered by an abnormal TSH, must be supported by documentation showing the reflex logic was followed and clinically appropriate. TransLabs builds these reflex rules directly into claim validation.
Specialized endocrine and neuroendocrine tumor marker tests billed under unlisted chemistry codes require a detailed cover letter describing the test methodology and clinical necessity. TransLabs prepares this documentation as a standard part of unlisted code claim submission.
The CLFS sets Medicare payment rates for endocrine and hormone testing and updates annually on January 1, while laboratories meeting the applicable laboratory definition under PAMA carry mandatory private payer data reporting obligations. TransLabs monitors CLFS changes and tracks your PAMA obligations to ensure accurate, on-time compliance.
Most billing companies have never coded a multi-hour evocative testing panel and don’t know these codes represent multiple timed draws, not a single service. TransLabs was built for laboratory billing exclusively; our endocrine team understands both routine hormone panels and dynamic testing protocols; no divided attention, no generalist assumptions.
Dedicated billing specialist assigned to your practice or lab
Complimentary 12-month claims audit across Medicare, Medicaid, and commercial payers
Uncover your top 3 revenue leaks (panel undercounting, reflex gaps, frequency denials)
Custom strategy tailored to your test menu and EHR/LIS software
Live in 24 hours with no contracts and no upfront fees
Pay only a percentage of what we collect for you